Clinical Trials in San Diego

Showing 8281-8300 of 11,146 trials

Sudden Deafness Treatment Trial

NCT00097448

This trial aims to compare the efficacy of oral prednisone vs. methylprednisolone injected into the middle ear for the treatment of moderate-to-severe, sudden sensorineural hearing loss (inner ear hearing loss affecting one ear that occurs over less than 72 hours).

Sudden Deafness

Massachusetts Eye and Ear Infirmary255 participantsStarted Dec 2004

Los Angeles, California, United States • San Diego, California, United States • Gainesville, Florida, United States +11 more locations

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD); (PINNACLE 1)

NCT01854645

The overall objective of this study is to assess the efficacy and safety of treatment with PT003 (GFF MDI), PT005 (FF MDI), PT001 (GP MDI), and open-label tiotropium bromide inhalation powder compared with each other and Placebo MDI over 24 weeks in subjects with moderate to very severe COPD.

Chronic Obstructive Pulmonary Disease

Pearl Therapeutics, Inc.2,103 participantsStarted May 2013

Andalusia, Alabama, United States • Anniston, Alabama, United States • Athens, Alabama, United States +136 more locations

Sudden Deafness Treatment Trial

Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD); (PINNACLE 1)

Find Trials by Condition in San Diego

Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital

Study In People With Type 2 Diabetes

Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients

Retapamulin Versus Linezolid in the Treatment of SITL and Impetigo Due to MRSA

A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson's Disease

An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease

Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases

A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry

Evaluation of Outcomes for Quality of Life and Activities of Daily Living for BKP in the Treatment of VCFs

Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth

Tobramycin Inhalation Powder (TIP) Administered Once Daily Continuously Versus TIP Administered BID in 28 Day on / 28 Day Off Cycles

STIP: Statin Trial for Influenza Patients

Clinical Trial of Peripheral Prism Glasses for Hemianopia

Effectiveness of Arginine as a Treatment for Sickle Cell Anemia

Post-Approval Study to Investigate the Long Term (8 Year) Survivorship of STAR Ankle Among Continued Access Study Patients

Improving Care and Reducing Cost Study

Caffeine as a Therapy for Parkinson's Disease